Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

被引：0
|
作者：
I. Watermann
B. Schmitt
F. Stellmacher
J. Müller
R. Gaber
Ch. Kugler
N. Reinmuth
R. M. Huber
M. Thomas
P. Zabel
K. F. Rabe
D. Jonigk
A. Warth
E. Vollmer
M. Reck
T. Goldmann
机构：
[1] Clinical and Experimental Pathology,
[2] Research Center Borstel,undefined
[3] LungenClinic Grosshansdorf,undefined
[4] Airway Research Center North (ARCN),undefined
[5] Member of the German Center for Lung Research (DZL),undefined
[6] Ludwig Maximilians University (LMU),undefined
[7] Comprehensive Pneumology Center Munich,undefined
[8] (CPC-M),undefined
[9] Member of the German Center for Lung Research,undefined
[10] Thoracic Oncology Centre Munich,undefined
[11] Medical Clinic,undefined
[12] Research Center Borstel,undefined
[13] Institute of Pathology,undefined
[14] Hannover Medical School,undefined
[15] Biomedical Research in Endstage and Obstructive Lung Disease Hanover (BREATH),undefined
[16] Member of the German Center for Lung Research,undefined
[17] Institute of Pathology,undefined
[18] Heidelberg University,undefined
[19] Translational Lung Research Center (TLRC),undefined
[20] Member of the German Center for Lung Research,undefined
[21] Pathology,undefined
[22] Faculty of Medicine,undefined
[23] Alexandria University,undefined
来源：
Diagnostic Pathology | / 10卷
关键词：
Non-small cell lung Cancer (NSCLC); MET; Targeted therapies; Diagnostic; Phosphorylated MET; Immunohistochemistry; Fluorescence in situ hybridization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    Watermann, I.
    Schmitt, B.
    Stellmacher, F.
    Mueller, J.
    Gaber, R.
    Kugler, Ch.
    Reinmuth, N.
    Huber, R. M.
    Thomas, M.
    Zabel, P.
    Rabe, K. F.
    Jonigk, D.
    Warth, A.
    Vollmer, E.
    Reck, M.
    Goldmann, T.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [2] Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Ma, Haichun
    Zhao, Yutong
    ONCOLOGY RESEARCH, 2020, 28 (05) : 497 - 507
  • [3] Fexofenadine Overcomes Osimertinib Resistance by Inhibiting c-Met in Non-Small Cell Lung Cancer
    To, Kenneth K. W.
    Leung, Kwong-Sak
    Cho, William C.
    MEDCOMM-ONCOLOGY, 2025, 4 (02):
  • [4] Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer
    Gao, Hong-Fei
    Li, An-Na
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Xie, Zhi
    Zhang, Xu-Chao
    Su, Jian
    Lou, Na-Na
    Yan, Hong-Hong
    Han, Jie-Fei
    Wu, Yi-Long
    CLINICAL LUNG CANCER, 2017, 18 (01) : 85 - 91
  • [5] Amplification and Overexpression of MET in Brain Metastases of Non-Small Cell Lung Cancer
    Akyurek, N.
    Ercan, C.
    Ekinci, O.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1040 - S1040
  • [6] Meeting an un-MET need: Targeting MET in non-small cell lung cancer
    Michaels, Elena
    Bestvina, Christine M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance
    Sacco, Joseph J.
    Clague, Michael J.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (03) : 242 - 252
  • [8] The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
    Ye, Sa
    Li, Jiuke
    Hao, Ke
    Yan, Jianping
    Zhou, Hongbin
    SCIENTIFIC REPORTS, 2016, 6
  • [9] Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
    Spagnolo, Calogera Claudia
    Ciappina, Giuliana
    Giovannetti, Elisa
    Squeri, Andrea
    Granata, Barbara
    Lazzari, Chiara
    Pretelli, Giulia
    Pasello, Giulia
    Santarpia, Mariacarmela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [10] Targeting un-MET needs in advanced non-small cell lung cancer
    Coleman, Niamh
    Harbery, Alice
    Heuss, Sara
    Vivanco, Igor
    Popat, Sanjay
    LUNG CANCER, 2022, 164 : 56 - 68
12345